2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC
- PMID: 32860505
- DOI: 10.1093/eurheartj/ehaa612
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC
Erratum in
-
Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).Eur Heart J. 2021 Feb 1;42(5):507. doi: 10.1093/eurheartj/ehaa798. Eur Heart J. 2021. PMID: 33029625 No abstract available.
-
Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).Eur Heart J. 2021 Feb 1;42(5):546-547. doi: 10.1093/eurheartj/ehaa945. Eur Heart J. 2021. PMID: 33242070 No abstract available.
-
Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.Eur Heart J. 2021 Oct 21;42(40):4194. doi: 10.1093/eurheartj/ehab648. Eur Heart J. 2021. PMID: 34520521 No abstract available.
Keywords: ABC pathway; AF surgery; Guidelines; antiarrhythmic drugs; anticoagulation; atrial fibrillation; cardioversion; catheter ablation; left atrial ablation; left atrial appendage occlusion; non-vitamin K antagonist oral anticoagulants; pulmonary vein isolation; rate control; recommendations; rhythm control; screening; stroke; upstream therapy; vitamin K antagonists.
Comment in
-
Uninterrupted vs. interrupted non-vitamin K antagonist oral anticoagulant during atrial fibrillation catheter ablation: expert opinion or true evidence?Eur Heart J. 2021 Jul 31;42(29):2866-2867. doi: 10.1093/eurheartj/ehaa1000. Eur Heart J. 2021. PMID: 33294920 No abstract available.
-
Personalized anti-thrombotic management of patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1 — a statement of the ESC Working Group on Cardiovascular Pharmacotherapy and ESC Council on Stroke [corrected].Eur Heart J. 2021 Feb 1;42(5):541-543. doi: 10.1093/eurheartj/ehaa1081. Eur Heart J. 2021. PMID: 33496325 No abstract available.
-
Focus on atrial fibrillation, syncope, and arrhythmias during COVID-19 pandemic.Eur Heart J. 2021 Feb 1;42(5):361-364. doi: 10.1093/eurheartj/ehab031. Eur Heart J. 2021. PMID: 33532851 Free PMC article. No abstract available.
-
Comments on the 2020 ESC/EACTS guidelines for the management of atrial fibrillation.Rev Esp Cardiol (Engl Ed). 2021 May;74(5):378-383. doi: 10.1016/j.rec.2020.11.023. Epub 2021 Mar 15. Rev Esp Cardiol (Engl Ed). 2021. PMID: 33736964 English, Spanish. No abstract available.
-
From Bench to Bedside-Implementing the New ABC Approach for Atrial Fibrillation in an Emergency Department Setting.Int J Environ Res Public Health. 2022 Apr 15;19(8):4797. doi: 10.3390/ijerph19084797. Int J Environ Res Public Health. 2022. PMID: 35457664 Free PMC article.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical